![Danilo Casadei-Massari](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Danilo Casadei-Massari
Amministratore Delegato presso
Nemysis Ltd.
Profilo
Danilo Casadei-Massari is the founder.
He founded CM&D Pharma Ltd. in 2007, where he held the title of Board Member & Director-Corporate Development from 2007 to 2009.
He also founded Nemysis Ltd. in 2005 and currently serves as the Chairman & Chief Executive Officer.
In 2011, he founded Prismic Pharmaceuticals, Inc. and served as the Director & President-Europe from 2013 to 2019.
Dr. Casadei-Massari's current job(s) include being the Chairman of ExPharma Ltd., an Independent Director at TargEDys SA since 2017, and a Director at Glycemicon AG.
His former job(s) include being a Director at Ajinomoto Cambrooke, Inc., a Principal at Fidia Farmaceutici SpA, a Vice President-Corporate Development at Sinclair Pharma Plc, and a member of the Investment Committee at Seventure Partners SA. Dr. Casadei-Massari obtained his undergraduate and doctorate degrees from the University of Padua.
Posizioni attive di Danilo Casadei-Massari
| Società | Posizione | Inizio |
|---|---|---|
Nemysis Ltd.
 Nemysis Ltd. BiotechnologyHealth Technology Operates as a healthcare and pharmaceutical company | Amministratore Delegato | - |
ExPharma Ltd.
 ExPharma Ltd. BiotechnologyHealth Technology Provides food development | Presidente | - |
TargEDys SA
 TargEDys SA BiotechnologyHealth Technology Develops and manufactures nutritional solutions to control metabolic diseases | Direttore/Membro del Consiglio | 11/04/2017 |
Glycemicon AG
 Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Develops novel nutraceuticals | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Danilo Casadei-Massari
| Società | Posizione | Fine |
|---|---|---|
Prismic Pharmaceuticals, Inc.
 Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Fondatore | 01/05/2019 |
Ajinomoto Cambrooke, Inc.
 Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets oral nutrition powders and shakes | Direttore/Membro del Consiglio | - |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Membro del Comitato di Investimento | - |
Fidia Farmaceutici SpA
 Fidia Farmaceutici SpA Pharmaceuticals: OtherHealth Technology Engages in research, development, production and marketing of hyaluronic acid & related products | Corporate Officer/Principal | - |
CM&D Pharma Ltd.
 CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fondatore | - |
Formazione di Danilo Casadei-Massari
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Fidia Farmaceutici SpA
Fidia Farmaceutici SpA Pharmaceuticals: OtherHealth Technology Engages in research, development, production and marketing of hyaluronic acid & related products | Health Technology |
Sinclair Pharma Plc /Old/
 Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Develops and wholesales pharmaceutical products | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
University of Padua
 University of Padua Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ajinomoto Cambrooke, Inc.
Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets oral nutrition powders and shakes | Health Technology |
Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology Develops and manufactures nutritional solutions to control metabolic diseases | Health Technology |
ExPharma Ltd.
ExPharma Ltd. BiotechnologyHealth Technology Provides food development | Health Technology |
Nemysis Ltd.
Nemysis Ltd. BiotechnologyHealth Technology Operates as a healthcare and pharmaceutical company | Health Technology |
Glycemicon AG
Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Develops novel nutraceuticals | Commercial Services |
